Oregon Evidence-based Practice Center to review bone growth product
Yale School of Medicine has chosen the Oregon Evidence-based Practice Center at Oregon Health & Science University as one of two research centers that will independently review all clinical studies of a controversial product used in spinal surgeries to promote bone growth.
The selection of the Oregon Evidence-based Practice Center comes after Yale had entered into an unusual agreement with Medtronic, the manufacturer of the bone growth product — called bone morphogenetic protein-2 — to independently review the product.
That agreement came after questions had been raised, in major newspapers, a major medical journal and elsewhere, about the product’s safety and efficacy.
- The entire OHSU media release is available online
